TNF and neoplasm: It has been proven that MUC-1-protein-functionalized GNPs serve as a powerful macrophage activator, promoting the release of TNF-α, IL-6, IL-10, and IL-12 on peritoneal macrophages, resulting in predominant M1 polarization, which showed a promising prospect as a tumor vaccine [138].